LIGAND PHARMACEUTICALS (LGND) Stock Cash Flow
USA - NASDAQ:LGND - US53220K5048 - Common Stock
170.65 USD
-0.12 (-0.07%)
171.49 USD
+0.84 (+0.49%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -75.86M | -4.03M | 52.15M | -33.40M | 57.10M | |||
| Depreciation Amortization | 34.53M | 35.24M | 36.52M | 51.50M | 51.10M | |||
| Income Taxes - Deferred | -23.85M | -15.80M | 11.70M | 20.70M | -8.60M | |||
| Change In Working Capital | 4.57M | 19.36M | -34.40M | 65.70M | -52.20M | |||
| Interest Paid | 354.00K | 263.00K | 288.00K | 1.40M | 3.00M | |||
| Taxes Paid | 17.99M | 19.21M | 8.77M | 11.60M | 3.70M | |||
| Other non cash items | 112.46M | 62.28M | -16.39M | 33.30M | 31.40M | |||
| OPERATING CASH FLOW | 52.58M | 97.05M | 49.58M | 137.90M | 78.80M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.74M | -1.82M | -64.25M | -17.90M | -8.80M | |||
| Other Investing Activity | -89.19M | -141.84M | 52.57M | 181.50M | 39.30M | |||
| INVESTING CASH FLOW | -90.44M | -143.66M | -11.68M | 163.60M | 30.50M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -29.00K | -25.00K | -76.90M | -261.00M | -164.90M | |||
| Stock Issued/Repurchased | 90.19M | 102.73M | 22.45M | 3.20M | 15.30M | |||
| Other Financing Activity | -4.59M | -5.56M | -5.50M | -18.20M | 11.90M | |||
| FINANCING CASH FLOW | 85.39M | 97.14M | -59.95M | -276.00M | -137.80M | |||
| Exchange Rate Effect | N/A | -1.17M | N/A | N/A | 0.00 | |||
| CHANGE IN CASH | 49.72M | 49.35M | -22.05M | 25.50M | -28.50M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 52.58M | 97.05M | 49.58M | 137.90M | 78.80M | |||
| Capital Expenditure | -1.74M | -1.82M | -64.25M | -17.90M | -8.80M | |||
| FREE CASH FLOW | 50.84M | 95.23M | -14.68M | 120.00M | 70.00M | |||
All data in USD